Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active.
NCT06334744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2024-03-29
Summary
To evaluate the serum neutralizing antibody titre in cancer patients undergoing active treatment against variants (VOC) before and after the third dose of BNT162b2 COVID-19 vaccine.
Conditions
- Oncologic Complications
Sponsors & Collaborators
-
Fondazione IRCCS Policlinico San Matteo di Pavia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-17
- Primary Completion
- 2023-01-08
- Completion
- 2023-06-08
Countries
- Italy
Study Locations
More Related Trials
-
Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease
NCT03347318 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor
NCT07327294 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
NCT07265921 ·Status: RECRUITING ·Phase: PHASE1
-
COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
NCT06168032 ·Status: RECRUITING ·Phase: NA
-
RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors
NCT05122572 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient
NCT02333474 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
NCT05340491 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
NCT03034304 ·Status: TERMINATED ·Phase: PHASE1
-
A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors
NCT05747339 ·Status: UNKNOWN ·Phase: NA
-
Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC
NCT06837948 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors
NCT03472352 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study of ICP-192 in Solid Tumors Patients
NCT03758664 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03047265 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors
NCT06346041 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer
NCT03598517 ·Status: UNKNOWN ·Phase: NA
-
Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors
NCT06724042 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of BPI-460372 in Advanced Solid Tumor Patients
NCT05789602 ·Status: RECRUITING ·Phase: PHASE1
-
NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies
NCT05605496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
NCT06799637 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.
NCT05203601 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MG2512 Injection in Participants With Advanced Solid Tumors
NCT07348653 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
NCT06007586 ·Status: COMPLETED ·Phase: PHASE3
-
Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy
NCT03689556 ·Status: UNKNOWN
-
A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases
NCT07249892 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2